Developing new ways to monitor autoimmune diseases like multiple sclerosis.
Official title: Supplement to Immunological Niches and Noninvasive Biosensors for Autoimmune Monitoring
Funded at University of Michigan at Ann Arbor · NIH-11237848 · Data updated 2026-11-12
This study is looking at new ways to keep an eye on multiple sclerosis by using special tools that can track how your immune system is working in real-time, which could help doctors create better, personalized treatments just for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | January 1, 2025 |
| Project end | May 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $94,265 |
| NIH project number | 3R00EB028840-05S2 |
| Project ID | NIH-11237848 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with multiple sclerosis or other autoimmune diseases.
✕Less likely to help
Patients with autoimmune conditions that do not involve the adaptive immune response may not benefit from this research.
What this research studies
This research focuses on improving the monitoring of multiple sclerosis (MS), an autoimmune disease known for its unpredictable relapses. The approach involves creating engineered immunological niches and biosensors that can detect immune responses in real-time without the need for invasive biopsies. By using tissue engineering and synthetic biology, the researchers aim to track the behavior of immune cells and cytokines in the body, which could lead to better management of the disease. Patients may benefit from more effective treatments that can be tailored based on their specific immune responses.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and management of multiple sclerosis, potentially reducing relapse rates and disease progression.
How similar studies have gone: Previous research has shown promise in using biosensors and tissue engineering for monitoring immune responses, indicating a potential for success in this novel approach.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Morris, Aaron Harvey — University of Michigan at Ann Arbor
- Study coordinator: Morris, Aaron Harvey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.